[{"id":"c9fc1c55-7d18-4160-96bb-efd244eef9cc","acronym":"STP-LYM-01","url":"https://clinicaltrials.gov/study/NCT01138579","created_at":"2021-01-18T04:31:37.432Z","updated_at":"2024-07-02T16:35:59.492Z","phase":"Phase 1/2","brief_title":"Study of the Trifunctional Antibody FBTA05 and Donor Lymphocyte Infusion in B-cell Lymphoma After Allogeneic Stem Cell Transplantation","source_id_and_acronym":"NCT01138579 - STP-LYM-01","lead_sponsor":"Technical University of Munich","biomarkers":" CD20","pipe":" | ","alterations":" CD20 positive","tags":["CD20"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD20 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lymphomun (FBTA05)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2010","start_date":" 08/01/2010","primary_txt":" Primary completion: 05/01/2015","primary_completion_date":" 05/01/2015","study_txt":" Completion: 06/01/2015","study_completion_date":" 06/01/2015","last_update_posted":"2022-12-07"}]